Daniel Ek, co-founder and CEO of Spotify, will open his latest venture, Neko Health, in New York City on September 24. The health-scanning startup, co-founded with Hjalmar Nilsonne, is set to establish its first American office at 300 Lafayette Street in SoHo. This move brings high-cost, proprietary health assessment technology directly to one of the nation's wealthiest neighborhoods. It signals a new frontier for capital accumulation in health services.
More than 25,000 New Yorkers have already joined a waitlist for Neko Health's services. This demonstrates a significant demand for health diagnostics, even those offered outside public systems. The company already operates in the U.K. and Sweden. Globally, 100,000 individuals have undergone scans. This rapid expansion represents a substantial investment in the privatization of health diagnostics, transforming a fundamental human need into a market opportunity for profit.
The Commodification of Health
Neko Health secured a $700 million Series C funding round last month. This massive capital injection fuels its aggressive growth into new markets. The company's business model relies on proprietary body-scanning technology, integrated with bloodwork and data from personal fitness devices, to offer a comprehensive health assessment. This approach systematically transforms personal health data and diagnostic capabilities into a commodity. It's accessible primarily to those with significant disposable income.
This trend isn't isolated. A growing number of health-scanning companies are emerging, founded by tech magnates or backed by venture capitalists. All seek to extract surplus value from health. Midjourney, an AI lab known for its image and video creation models, is developing its own body scanner. They plan to integrate it into a "spa experience" in San Francisco by 2027. This further illustrates how health services are being repackaged as luxury experiences for the affluent, rather than universal provisions.
Capital's New Frontier
Other prominent figures in capital accumulation are also aggressively entering this market. Tony Robbins and Peter Diamandis operate Fountain Life, a longevity company offering scans and health assessments. They position extended life as a purchasable good. Function Health, co-founded by wellness podcaster Dr. Mark Hyman, provides blood testing. It has expanded into body scans through the acquisition of Ezra. These ventures represent a concerted effort by capital to extract profit from the human desire for health and extended life, turning biological processes into revenue streams.
Function Health recently secured a $450 million loan from General Catalyst’s Customer Value Fund. This financing arrangement is structured so that companies repay the money through profit-sharing agreements. Such mechanisms ensure that the financial gains from these privatized health services flow directly back to the investment funds. This further concentrates wealth at the top. The expansion of Neko Health into New York marks another step in the systematic transformation of health from a universal right into a premium service for those who can afford it. It deepens class divisions in access to well-being.